| abstract |
The invention features methods and compositions for reducing levels of C-reactive protein (CRP), IL-6, and / or IFN-? in serum in a patient in need of it, and to treat diseases and conditions associated with levels of CRP, IL-6, and / or IFN-? increased serum. The invention also presents methods and compositions for treating a patient diagnosed with, or at risk of developing, periodontal disease by administering a corticosteroid or an analog thereof and / or a tetra-substituted pyrimidopyrimidine or an upward regulator of adenosine analog. |